On today’s episode of the Zacks Friday Finish Line podcast, Content Writer Ryan McQueeney and Editor Maddy Johnson take on this week’s biggest news from the investment and financial world.
The hosts kicked the show off by covering the drama that unfolded with Mylan and its EpiPen allergy medication this week. Mylan became the center of controversy after several notable healthcare reform advocates, including Democratic presidential nominee Hillary Clinton, criticized the company’s price hikes on the EpiPen over the past several years.
Just a day after Clinton took to Twitter to announce her plan to combat high drug prices and demand that Mylan lower the cost of the EpiPen, the drugmaker announced that it would be taking several steps to reduce the cost of the medication for some patients.
Check out our full coverage of the saga: Did Hillary Clinton's Tweet Cause the Sell-Off in Mylan Stock? & Mylan Listens to Critics, Will Make EpiPen More Affordable
Maddy and Ryan also talked about the latest rumor from Amazon (AMZN - Free Report) . According to reports, Amazon is working on a couple of new music streaming services, including one that would only cost $5 a month. However, that $5 a month service would be limited to Amazon’s line of Echo smart speakers, despite the music streaming industry’s reliance on mobile streaming.
For the full story, go here: What Amazon's New $5 Streaming Music Service Means for Its Future
Using Amazon’s Echo smart speaker as a catalyst, the hosts turned their attention to the broader Internet of Things market. With a look at the current state of Internet of Things technology, as well as a glimpse towards to the future of IoT products, Maddy and Ryan had an extensive conversation about the latest trend in tech.
For more on the Internet of Things, check out our latest coverage: How to Invest in the "Internet of Things" & 3 "Internet of Things" Stocks to Buy Now
As always, thanks for checking out this week’s episode of the Zacks Friday Finish Line, and make sure to check back next week for even more news from the investment and financial world!
Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report >>
Zacks Names "Single Best Pick to Double"
From thousands of stocks, 5 Zacks experts each have chosen their favorite to skyrocket +100% or more in months to come. From those 5, Director of Research Sheraz Mian hand-picks one to have the most explosive upside of all.
It’s a little-known chemical company that’s up 65% over last year, yet still dirt cheap. With unrelenting demand, soaring 2022 earnings estimates, and $1.5 billion for repurchasing shares, retail investors could jump in at any time.
This company could rival or surpass other recent Zacks’ Stocks Set to Double like Boston Beer Company which shot up +143.0% in little more than 9 months and NVIDIA which boomed +175.9% in one year.
Free: See Our Top Stock and 4 Runners Up >>
On today’s episode of the Zacks Friday Finish Line podcast, Content Writer Ryan McQueeney and Editor Maddy Johnson take on this week’s biggest news from the investment and financial world.
The hosts kicked the show off by covering the drama that unfolded with Mylan and its EpiPen allergy medication this week. Mylan became the center of controversy after several notable healthcare reform advocates, including Democratic presidential nominee Hillary Clinton, criticized the company’s price hikes on the EpiPen over the past several years.
Just a day after Clinton took to Twitter to announce her plan to combat high drug prices and demand that Mylan lower the cost of the EpiPen, the drugmaker announced that it would be taking several steps to reduce the cost of the medication for some patients.
Check out our full coverage of the saga: Did Hillary Clinton's Tweet Cause the Sell-Off in Mylan Stock? & Mylan Listens to Critics, Will Make EpiPen More Affordable
Maddy and Ryan also talked about the latest rumor from Amazon (AMZN - Free Report) . According to reports, Amazon is working on a couple of new music streaming services, including one that would only cost $5 a month. However, that $5 a month service would be limited to Amazon’s line of Echo smart speakers, despite the music streaming industry’s reliance on mobile streaming.
For the full story, go here: What Amazon's New $5 Streaming Music Service Means for Its Future
Using Amazon’s Echo smart speaker as a catalyst, the hosts turned their attention to the broader Internet of Things market. With a look at the current state of Internet of Things technology, as well as a glimpse towards to the future of IoT products, Maddy and Ryan had an extensive conversation about the latest trend in tech.
For more on the Internet of Things, check out our latest coverage: How to Invest in the "Internet of Things" & 3 "Internet of Things" Stocks to Buy Now
As always, thanks for checking out this week’s episode of the Zacks Friday Finish Line, and make sure to check back next week for even more news from the investment and financial world!
Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report >>
Zacks Names "Single Best Pick to Double"
From thousands of stocks, 5 Zacks experts each have chosen their favorite to skyrocket +100% or more in months to come. From those 5, Director of Research Sheraz Mian hand-picks one to have the most explosive upside of all.
It’s a little-known chemical company that’s up 65% over last year, yet still dirt cheap. With unrelenting demand, soaring 2022 earnings estimates, and $1.5 billion for repurchasing shares, retail investors could jump in at any time.
This company could rival or surpass other recent Zacks’ Stocks Set to Double like Boston Beer Company which shot up +143.0% in little more than 9 months and NVIDIA which boomed +175.9% in one year.
Free: See Our Top Stock and 4 Runners Up >>
Get the latest research report on AMZN - FREE